SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001193125-22-034471
Filing Date
2022-02-10
Accepted
2022-02-10 16:19:55
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d273295dsc13ga.htm SC 13G/A 41036
  Complete submission text file 0001193125-22-034471.txt   42365
Mailing Address ONE CORPORATE DR., 2ND FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address ONE CORPORATE DR., 2ND FLOOR SOUTH SAN FRANCISCO CA 94080 (800) 466-6059
Aligos Therapeutics, Inc. (Subject) CIK: 0001799448 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-91770 | Film No.: 22614227
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O ALIGOS THERAPEUTICS, INC. ONE CORPORATE DRIVE, 2ND FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address
Beigelman Leonid (Filed by) CIK: 0001824721 (see all company filings)

Type: SC 13G/A